Journal: International Journal of Surgery (London, England)
Article Title: Shock wave-pretreated ADMSCs of cell-sheet scaffold (CSS) patched on the left ventricular wall (LVW) inhibited LVW remodeling in mini-pig MI: role of CSS on counteracting Laplace’s Law of LVW stress – experimental study
doi: 10.1097/JS9.0000000000002119
Figure Lengend Snippet: Effect of SW and ADMSCs on alleviating inflammation, oxidative stress and apoptosis. (A) Western blot result of MMP-9, * versus other groups with different symbols (†, ‡, §), P <0.0001. (B) Western blot result of interleukin (IL)-6, * versus other groups with different symbols (†, ‡, δ), P <0.0001. (C) Western blot result of COX-2, * versus other groups with different symbols (†, ‡, §), P <0.0001. (D) Western blot result of interferon (IFN)-γ, * versus other groups with different symbols (†, ‡, §), P <0.0001. (E) Western blot result of NOX-1, * versus other groups with different symbols (†, ‡, §), P <0.0001. (F) Western blot result of NOX-2, * versus other groups with different symbols (†, ‡, §), P <0.0001. (G) Flow cytometric assessment of early (AN-V + /PI − ) apoptosis, * versus other groups with different symbols (†, ‡, §), P <0.0001. (H) Flow cytometric assessment of late (AN-V + /PI + ) apoptosis, * versus other groups with different symbols (†, ‡, §), P <0.0001. (I-1) Number of M1 surface expression in Raw 264.7 Cells, * versus other groups with different symbols (†, ‡, §), P <0.0001. (I-2) Number of M2 surface expression in Raw 264.7 Cells, * versus other groups with different symbols (†, ‡, §), P <0.0001. (I-3) Ratio of M2/M1, * versus other groups with different symbols (†, ‡, §), P <0.0001. All statistical analyses were performed by one-way ANOVA, followed by Bonferroni multiple-comparison post hoc test ( n = 6 for each group). Symbols (*, †, ‡, §) express significance for each other (at 0.05 level). ADMSCs, adipose-derived mesenchymal stem cells; LPS, lipopolysaccharide; SW, shock wave.
Article Snippet: The membranes were incubated with the indicated primary antibodies [vascular endothelial growth factor (VEGF; 1:1000, Abcam), stromal cell-derived factor-1α (SDF-1α; 1:1000, Cell Signaling), C-X-C chemokine receptor type 4 (CXCR4; 1:1000, Abcam), angioetin-1 (1:1000, Abcam), bone morphogenetic protein-2 (BMP-2; 1:1000, Abcam), phosphorylated Smad1/5 (1:1000, Cell Signaling), von Willebrand factor (vWF; 1:1000, Abcam), endothelial nitric oxide synthase (eNOS; 1:1000, Abcam), angiopoietin-1 (1:1000, Abcam), cytosolic cytochrome (1:5000, BD), mitochondrial cytochrome C (1:5000, BD), γ-H2AX (1:1000, Cell Signaling), phosphorylated Smad3 (1:1000, Cell Signaling), transforming growth factor β (TGF)-β (1:1000, Abcam), complex I (1:5000, Abcam), complex II (1:5000, Abcam), complex III (1:5000, Abcam), complex IV (1:5000, Abcam), complex V (1:5000, Abcam), matrix metalloproteinase-9 (MMP-9; 1:1000, Abcam), interleukin-6 (IL-6; 1:1000, Abcam), cyclooxygenase-2 ([COX-2; 1:1000, Abcam), interferon gamma (IFN-γ; 1:1000, Abcam), NADPH oxidase (NOX-1; 1:1000, Sigma), NOX-2 (1:1000, Sigma), mitochondria respiratory chain (MRC I; 1:5000, Abcam), MRC II (1:5000, Abcam), MRC III (1:5000, Abcam), and MRC IV (1:5000, Abcam)] for 1 h at room temperature.
Techniques: Western Blot, Expressing, Comparison, Derivative Assay